Aki Georgacacos, Managing Director and co-founder at Avrio, will join Jonathan Ross Goodman, co-founder and former CEO of publicly traded Paladin Labs Inc., and founder and CEO of publicly traded Knight Therapeutics Inc. (TSX:GUD) as lead investor and Board member. This cash injection will help Montreal-based FODY accelerate its USA and Canadian distribution presence both online and in retail, and develop new products so craved by the 15% of Americans with some form of IBS. Steven J. Singer, the co-founder of gluten free success story Glutino Inc. ("Glutino") and founder and CEO of FODY, sees lots of similarities between the two companies.